Cost analysis of paediatric tuberculosis treatment in Japan

Mahbubur Rahman, O. Takahashi, I. Takamatsu, M. Sekimoto, K. Hira, T. Fukui

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

OBJECTIVE: To estimate the cost of treating a tuberculosis (TB) case and to analyse TB-related medical service utilisation, a cost-of-illness study was conducted for all patients with a primary diagnosis of TB admitted to a public hospital in Japan. METHODS: Retrospective analysis by abstracting in- and out-patient medical records of 57 paediatric patients diagnosed with TB during 1993-1998 at a public hospital in Osaka prefecture. Costs were estimated based on third party's payer perspectives according to the service utilisation pattern. In addition to cost data, sociodemographic information and service utilisation pattern were also extracted from the medical records. Cost of preventing a case of TB was abstracted from the published literature. RESULTS: The average cost of treatment was US$8384 (95 %CI 5667-11099), while the average length of hospitalisation was 63 days (95%CI 43-84). Based on 20-80% vaccine efficacy, the cost of preventing a case of TB was US$35 950-175 862. In univariate analysis, site of TB (P = 0.04) was significantly associated with TB treatment cost, while case-finding method (contact tracing, symptoms, etc.) was associated with length of hospitalisation (P = 0.03). Multivariate regression analysis, however, showed none of the factors to be significant predictors of TB treatment cost and length of hospital stay. CONCLUSION: The cost of treating a case of paediatric TB is much lower than that of preventing one. Japan's universal BCG vaccination policy should be re-examined in the light of economic, social and political issues.

Original languageEnglish (US)
Pages (from-to)254-257
Number of pages4
JournalInternational Journal of Tuberculosis and Lung Disease
Volume7
Issue number3
StatePublished - Mar 1 2003
Externally publishedYes

Fingerprint

Japan
Tuberculosis
Pediatrics
Costs and Cost Analysis
Health Care Costs
Therapeutics
Public Hospitals
Medical Records
Length of Stay
Hospitalization
Contact Tracing
Health Insurance Reimbursement
Cost of Illness
Information Services
Mycobacterium bovis
Vaccination
Outpatients
Vaccines
Multivariate Analysis
Regression Analysis

Keywords

  • Bacillus Calmette-Guérin
  • Costs
  • Japan
  • Tuberculosis

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Rahman, M., Takahashi, O., Takamatsu, I., Sekimoto, M., Hira, K., & Fukui, T. (2003). Cost analysis of paediatric tuberculosis treatment in Japan. International Journal of Tuberculosis and Lung Disease, 7(3), 254-257.

Cost analysis of paediatric tuberculosis treatment in Japan. / Rahman, Mahbubur; Takahashi, O.; Takamatsu, I.; Sekimoto, M.; Hira, K.; Fukui, T.

In: International Journal of Tuberculosis and Lung Disease, Vol. 7, No. 3, 01.03.2003, p. 254-257.

Research output: Contribution to journalArticle

Rahman, M, Takahashi, O, Takamatsu, I, Sekimoto, M, Hira, K & Fukui, T 2003, 'Cost analysis of paediatric tuberculosis treatment in Japan', International Journal of Tuberculosis and Lung Disease, vol. 7, no. 3, pp. 254-257.
Rahman M, Takahashi O, Takamatsu I, Sekimoto M, Hira K, Fukui T. Cost analysis of paediatric tuberculosis treatment in Japan. International Journal of Tuberculosis and Lung Disease. 2003 Mar 1;7(3):254-257.
Rahman, Mahbubur ; Takahashi, O. ; Takamatsu, I. ; Sekimoto, M. ; Hira, K. ; Fukui, T. / Cost analysis of paediatric tuberculosis treatment in Japan. In: International Journal of Tuberculosis and Lung Disease. 2003 ; Vol. 7, No. 3. pp. 254-257.
@article{542b877e3116431aaa36d0823cbe6f8b,
title = "Cost analysis of paediatric tuberculosis treatment in Japan",
abstract = "OBJECTIVE: To estimate the cost of treating a tuberculosis (TB) case and to analyse TB-related medical service utilisation, a cost-of-illness study was conducted for all patients with a primary diagnosis of TB admitted to a public hospital in Japan. METHODS: Retrospective analysis by abstracting in- and out-patient medical records of 57 paediatric patients diagnosed with TB during 1993-1998 at a public hospital in Osaka prefecture. Costs were estimated based on third party's payer perspectives according to the service utilisation pattern. In addition to cost data, sociodemographic information and service utilisation pattern were also extracted from the medical records. Cost of preventing a case of TB was abstracted from the published literature. RESULTS: The average cost of treatment was US$8384 (95 {\%}CI 5667-11099), while the average length of hospitalisation was 63 days (95{\%}CI 43-84). Based on 20-80{\%} vaccine efficacy, the cost of preventing a case of TB was US$35 950-175 862. In univariate analysis, site of TB (P = 0.04) was significantly associated with TB treatment cost, while case-finding method (contact tracing, symptoms, etc.) was associated with length of hospitalisation (P = 0.03). Multivariate regression analysis, however, showed none of the factors to be significant predictors of TB treatment cost and length of hospital stay. CONCLUSION: The cost of treating a case of paediatric TB is much lower than that of preventing one. Japan's universal BCG vaccination policy should be re-examined in the light of economic, social and political issues.",
keywords = "Bacillus Calmette-Gu{\'e}rin, Costs, Japan, Tuberculosis",
author = "Mahbubur Rahman and O. Takahashi and I. Takamatsu and M. Sekimoto and K. Hira and T. Fukui",
year = "2003",
month = "3",
day = "1",
language = "English (US)",
volume = "7",
pages = "254--257",
journal = "International Journal of Tuberculosis and Lung Disease",
issn = "1027-3719",
publisher = "International Union against Tubercul. and Lung Dis.",
number = "3",

}

TY - JOUR

T1 - Cost analysis of paediatric tuberculosis treatment in Japan

AU - Rahman, Mahbubur

AU - Takahashi, O.

AU - Takamatsu, I.

AU - Sekimoto, M.

AU - Hira, K.

AU - Fukui, T.

PY - 2003/3/1

Y1 - 2003/3/1

N2 - OBJECTIVE: To estimate the cost of treating a tuberculosis (TB) case and to analyse TB-related medical service utilisation, a cost-of-illness study was conducted for all patients with a primary diagnosis of TB admitted to a public hospital in Japan. METHODS: Retrospective analysis by abstracting in- and out-patient medical records of 57 paediatric patients diagnosed with TB during 1993-1998 at a public hospital in Osaka prefecture. Costs were estimated based on third party's payer perspectives according to the service utilisation pattern. In addition to cost data, sociodemographic information and service utilisation pattern were also extracted from the medical records. Cost of preventing a case of TB was abstracted from the published literature. RESULTS: The average cost of treatment was US$8384 (95 %CI 5667-11099), while the average length of hospitalisation was 63 days (95%CI 43-84). Based on 20-80% vaccine efficacy, the cost of preventing a case of TB was US$35 950-175 862. In univariate analysis, site of TB (P = 0.04) was significantly associated with TB treatment cost, while case-finding method (contact tracing, symptoms, etc.) was associated with length of hospitalisation (P = 0.03). Multivariate regression analysis, however, showed none of the factors to be significant predictors of TB treatment cost and length of hospital stay. CONCLUSION: The cost of treating a case of paediatric TB is much lower than that of preventing one. Japan's universal BCG vaccination policy should be re-examined in the light of economic, social and political issues.

AB - OBJECTIVE: To estimate the cost of treating a tuberculosis (TB) case and to analyse TB-related medical service utilisation, a cost-of-illness study was conducted for all patients with a primary diagnosis of TB admitted to a public hospital in Japan. METHODS: Retrospective analysis by abstracting in- and out-patient medical records of 57 paediatric patients diagnosed with TB during 1993-1998 at a public hospital in Osaka prefecture. Costs were estimated based on third party's payer perspectives according to the service utilisation pattern. In addition to cost data, sociodemographic information and service utilisation pattern were also extracted from the medical records. Cost of preventing a case of TB was abstracted from the published literature. RESULTS: The average cost of treatment was US$8384 (95 %CI 5667-11099), while the average length of hospitalisation was 63 days (95%CI 43-84). Based on 20-80% vaccine efficacy, the cost of preventing a case of TB was US$35 950-175 862. In univariate analysis, site of TB (P = 0.04) was significantly associated with TB treatment cost, while case-finding method (contact tracing, symptoms, etc.) was associated with length of hospitalisation (P = 0.03). Multivariate regression analysis, however, showed none of the factors to be significant predictors of TB treatment cost and length of hospital stay. CONCLUSION: The cost of treating a case of paediatric TB is much lower than that of preventing one. Japan's universal BCG vaccination policy should be re-examined in the light of economic, social and political issues.

KW - Bacillus Calmette-Guérin

KW - Costs

KW - Japan

KW - Tuberculosis

UR - http://www.scopus.com/inward/record.url?scp=0037347738&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037347738&partnerID=8YFLogxK

M3 - Article

VL - 7

SP - 254

EP - 257

JO - International Journal of Tuberculosis and Lung Disease

JF - International Journal of Tuberculosis and Lung Disease

SN - 1027-3719

IS - 3

ER -